BackVoyageur Pharmaceuticals Overview
Voyageur Pharmaceuticals Ltd.

Voyageur Pharmaceuticals Return on Equity

Voyageur Pharmaceuticals (VYYRF) has a ROE of -74.81%, below the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

-74.81%

Return on Equity

-74.81%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Voyageur Pharmaceuticals (VYYRF) FAQ

The latest ROE for VYYRF is -74.81%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Voyageur Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, VYYRF currently prints -74.81% for ROE, while the sector average sits near 11.3%. That is roughly 762.3% below the sector mean. Large gaps often invite a closer look at Voyageur Pharmaceuticals's growth, margins, and balance sheet.

Return on Equity shows how effectively Voyageur Pharmaceuticals converts resources into returns. At -74.81%, VYYRF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting VYYRF's ROE (-74.81%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.